Top Story

HbA1c levels CV events modestly related in type 2 diabetes

August 26, 2015

A modest, but not statistically significant, relationship was found between HbA1c levels and cardiovascular events in people with type 2 diabetes, according to recent study findings published in Diabetes Care.

There was no difference in relationship among people with or without clinical manifestation of vascular disease, according to the researchers.

Caroline Fox In the Journals

Updated guidelines address CVD prevention in adults with type 2 diabetes

August 19, 2015
The American Diabetes Association and the American Heart Association recently released a revised joint scientific statement outlining best practices to reduce…
In the Journals

Trans fats, not saturated fats, linked to increased mortality, CHD risks

August 14, 2015
Trans fat intake was associated with an increased risk for all-cause mortality and CHD; however, consuming saturated fats did not appear to influence risk for mortality…
In the Journals

Cardiac troponin T may predict CV events in diabetes, stable ischemic heart disease

August 12, 2015
Abnormal cardiac troponin T concentrations independently predicted CV death, MI or stroke in patients with diabetes and stable ischemic heart disease, according to a new…
Cardiology Case Consults

The Patient With Idiopathic Pulmonary Fibrosis

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with idiopathic pulmonary fibrosis.
More »
Meeting News Coverage Video
VIDEO: Expert discusses relationship between statin therapy, diabetes

VIDEO: Expert discusses relationship between statin therapy, diabetes

June 12, 2015
CHICAGO — Health care professionals should be aware of the link between statin use and increased risk for type 2…
More »
Keith C. Ferdinand Meeting News Coverage

Cardiometabolic Health Congress highlights latest research on CVD, diabetes, obesity

October 23, 2014
BOSTON — The latest innovative research in diabetes, hypertension, lipids, obesity and thrombosis was analyzed by experts at the…
In the Journals

Atherosclerosis risk increased among men with diabetes, low testosterone

October 17, 2014
A greater risk for developing atherosclerosis is found among middle-aged men with low testosterone and type 2 diabetes, according to recent study…
Meeting News Coverage

Biguanides, liraglutide reduced CVD risk in type 2 diabetes

September 24, 2014
Patients with type 2 diabetes treated with biguanides and liraglutide have a reduced risk for ischemic heart disease, heart failure and stroke…
Stijn Peeters Meeting News Coverage

Higher plasma levels linked to CV complications in type 1 diabetes

September 18, 2014
Cardiovascular complications are associated with higher plasma levels in patients with type 1 diabetes, according to a presenter at the 50th European…
In the Journals

Age, diabetes duration increases risk for macrovascular complications

September 12, 2014
For patients with type 2 diabetes, macrovascular events and death are associated with age or age at diagnosis and diabetes duration, according to…
Matthew J. Price, MD In the Journals

Clopidogrel response impaired among patients with diabetes, CAD

September 4, 2014
Patients with diabetes and CAD experienced an impaired response to platelet P2Y12 receptor antagonist clopidogrel compared with those without…
In the Journals

Insulin use, dialysis predicted poor wound healing after endovascular therapy

August 28, 2014
Patients undergoing endovascular therapy for critical limb ischemia were significantly more likely to have non-healing wounds if they used insulin…

Nutrition education lacking in medical training

August 26, 2014
A group of physicians are questioning how well doctors can provide nutrition information and counseling to patients, particularly those with CVD…

AHA and ADA: CV risk assessment, monitoring essential for patients with type 1 diabetes

August 21, 2014
A greater understanding of the pathophysiology, risk prediction and treatment of CVD in patients with type 1 diabetes is essential to minimize the…
Steven E. Nissen, MD, MACC FDA News

FDA opens dialogue on interim results of CV safety in diabetes drug trials

August 12, 2014
The FDA has launched a dialogue on how to handle confidentiality of the interim results for cardiovascular outcomes in diabetes treatment trials…
More Headlines »